{
  "ProtocolSection": {
    "IdentificationModule": {
      "NCTId": "NCT03696628",
      "OrgStudyIdInfo": {
        "OrgStudyId": "9806"
      },
      "SecondaryIdInfoList": {
        "SecondaryIdInfo": [
          {
            "SecondaryId": "2017-A01589-44",
            "SecondaryIdType": "Registry Identifier",
            "SecondaryIdDomain": "ID-RCB"
          }
        ]
      },
      "Organization": {
        "OrgFullName": "University Hospital, Montpellier",
        "OrgClass": "OTHER"
      },
      "BriefTitle": "Modeling and Pharmacological Targeting of Genetic Cardiomyopathy in Children Via Cardiomyocytes Derived From Induced Pluripotent Stem Cells (DMDstem)",
      "OfficialTitle": "Modeling and Pharmacological Targeting of Genetic Cardiomyopathy in Children Via Cardiomyocytes Derived From Induced Pluripotent Stem Cells",
      "Acronym": "DMDstem"
    },
    "StatusModule": {
      "StatusVerifiedDate": "December 2020",
      "OverallStatus": "Recruiting",
      "ExpandedAccessInfo": {
        "HasExpandedAccess": "No"
      },
      "StartDateStruct": {
        "StartDate": "September 25, 2017",
        "StartDateType": "Actual"
      },
      "PrimaryCompletionDateStruct": {
        "PrimaryCompletionDate": "April 2021",
        "PrimaryCompletionDateType": "Anticipated"
      },
      "CompletionDateStruct": {
        "CompletionDate": "April 2022",
        "CompletionDateType": "Anticipated"
      },
      "StudyFirstSubmitDate": "August 7, 2018",
      "StudyFirstSubmitQCDate": "October 3, 2018",
      "StudyFirstPostDateStruct": {
        "StudyFirstPostDate": "October 4, 2018",
        "StudyFirstPostDateType": "Actual"
      },
      "LastUpdateSubmitDate": "December 1, 2020",
      "LastUpdatePostDateStruct": {
        "LastUpdatePostDate": "December 3, 2020",
        "LastUpdatePostDateType": "Actual"
      }
    },
    "SponsorCollaboratorsModule": {
      "ResponsibleParty": {
        "ResponsiblePartyType": "Sponsor"
      },
      "LeadSponsor": {
        "LeadSponsorName": "University Hospital, Montpellier",
        "LeadSponsorClass": "OTHER"
      }
    },
    "OversightModule": {
      "OversightHasDMC": "No",
      "IsFDARegulatedDrug": "No",
      "IsFDARegulatedDevice": "No"
    },
    "DescriptionModule": {
      "BriefSummary": "Interventional, cross-sectional biomedical study of children with genetic cardiomyopathy and healthy children. The aim is to generate, via induced human pluripotent stem cells (hiPSC), \"patient-specific\" cardiomyocytes (CMs) (hiPSC-CMs) to study the molecular mechanisms of cardiomyopathies of genetic origin.",
      "DetailedDescription": "Interventional, cross-sectional biomedical study of children with genetic cardiomyopathy and healthy children. The aim is to generate, via induced human pluripotent stem cells (hiPSC), \"patient-specific\" cardiomyocytes (CMs) (hiPSC-CMs) to study the molecular mechanisms of cardiomyopathies of genetic origin.\n\nThe study will be proposed to the parents or legal guardians of the children from 0 to 17 included sent in pediatric cardiology consultation to the University Hospital of Montpellier as part of their usual follow-up or a health check (control) .\n\nThe only direct intervention performed on the patient is a venous blood sample. The volume of blood collected will be lower than the thresholds defined in the Decree of December 2nd, 2016 on minimal risks in biomedical research (3 ml)."
    },
    "ConditionsModule": {
      "ConditionList": {
        "Condition": [
          "Cardiomyopathy, Familial"
        ]
      },
      "KeywordList": {
        "Keyword": [
          "Cardiomyocytes",
          "Induced pluripotent stem cells",
          "Genetic cardiomyopathy"
        ]
      }
    },
    "DesignModule": {
      "StudyType": "Interventional",
      "PhaseList": {
        "Phase": [
          "Not Applicable"
        ]
      },
      "DesignInfo": {
        "DesignAllocation": "Non-Randomized",
        "DesignInterventionModel": "Parallel Assignment",
        "DesignInterventionModelDescription": "All participants receive the same intervention throughout the protocol, no matter if they are \"healthy children\" or \"cardiomyopathic children\".",
        "DesignPrimaryPurpose": "Basic Science",
        "DesignMaskingInfo": {
          "DesignMasking": "None (Open Label)",
          "DesignMaskingDescription": "Open : no masking us used. All involved know the identity of the intervention assignment."
        }
      },
      "EnrollmentInfo": {
        "EnrollmentCount": "24",
        "EnrollmentType": "Anticipated"
      }
    },
    "ArmsInterventionsModule": {
      "ArmGroupList": {
        "ArmGroup": [
          {
            "ArmGroupLabel": "Healthy children",
            "ArmGroupType": "Other",
            "ArmGroupDescription": "Blood test with generated hiPSC-cardiomyocytes Physical Examination. Electrocardiogram. Echocardiography.",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Other: Electrocardiogram",
                "Other: physical examination",
                "Other: echocardiography",
                "Biological: blood test"
              ]
            }
          },
          {
            "ArmGroupLabel": "Cardiomyopathic children",
            "ArmGroupType": "Other",
            "ArmGroupDescription": "Blood test with generated hiPSC-cardiomyocytes Physical Examination. Electrocardiogram. Echocardiography.",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Other: Electrocardiogram",
                "Other: physical examination",
                "Other: echocardiography",
                "Biological: blood test"
              ]
            }
          }
        ]
      },
      "InterventionList": {
        "Intervention": [
          {
            "InterventionType": "Other",
            "InterventionName": "Electrocardiogram",
            "InterventionDescription": "heart testing",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "Cardiomyopathic children",
                "Healthy children"
              ]
            }
          },
          {
            "InterventionType": "Other",
            "InterventionName": "physical examination",
            "InterventionDescription": "done by the investigator",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "Cardiomyopathic children",
                "Healthy children"
              ]
            }
          },
          {
            "InterventionType": "Other",
            "InterventionName": "echocardiography",
            "InterventionDescription": "heart testing",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "Cardiomyopathic children",
                "Healthy children"
              ]
            }
          },
          {
            "InterventionType": "Biological",
            "InterventionName": "blood test",
            "InterventionDescription": "A sample of blood will be taken to each patient or healthy children in order to generate hiPSC-cardiomyocytes",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "Cardiomyopathic children",
                "Healthy children"
              ]
            }
          }
        ]
      }
    },
    "OutcomesModule": {
      "PrimaryOutcomeList": {
        "PrimaryOutcome": [
          {
            "PrimaryOutcomeMeasure": "hiPSC-cardiomyocytes culture",
            "PrimaryOutcomeDescription": "Blood test with generated hiPSC-cardiomyocytes",
            "PrimaryOutcomeTimeFrame": "Inclusion visit"
          }
        ]
      }
    },
    "EligibilityModule": {
      "EligibilityCriteria": "Group 1 : Child with genetic cardiomyopathy\n\nInclusion criteria\n\nChild from 0 to 17 years old included\nBearer or at risk of cardiomyopathy of genetic origin. Written and informed consent of parents or guardians of legal guardians\nAffiliation or beneficiary of a social security scheme\n\nCriterion of non-inclusion\n\n. Cardiomyopathy of non-genetic origin (metabolic, toxic, malformative, etc.)\n\nGroup 2 : Healthy child\n\nInclusion criteria\n\nChildren aged 0 to 17 years old\nNormal assessment: clinical examination, ECG, echocardiography\nWritten and informed consent\nAffiliation or beneficiary of a social security scheme\n\nCriterion of non-inclusion\n\nHeart, muscle or respiratory disease\nTreatment with cardiac resonance\nOther chronic diseases (diabetes, neuropathy, kidney failure, tumor)",
      "HealthyVolunteers": "Accepts Healthy Volunteers",
      "Gender": "All",
      "MaximumAge": "17 Years",
      "StdAgeList": {
        "StdAge": [
          "Child"
        ]
      }
    },
    "ContactsLocationsModule": {
      "CentralContactList": {
        "CentralContact": [
          {
            "CentralContactName": "Pascal AMEDRO, PhD",
            "CentralContactRole": "Contact",
            "CentralContactPhone": "+33 (0) 4 67 33 66 39",
            "CentralContactEMail": "p-amedro@chu-montpellier.fr"
          }
        ]
      },
      "LocationList": {
        "Location": [
          {
            "LocationFacility": "CHU Arnaud de Villeneuve",
            "LocationStatus": "Recruiting",
            "LocationCity": "Montpellier",
            "LocationState": "Occitanie",
            "LocationZip": "34090",
            "LocationCountry": "France",
            "LocationContactList": {
              "LocationContact": [
                {
                  "LocationContactName": "Pascal AMEDRO, PhD",
                  "LocationContactRole": "Contact",
                  "LocationContactPhone": "+33 (0) 4 67 33 66 39",
                  "LocationContactEMail": "p-amedro@chu-montpellier.fr"
                }
              ]
            }
          }
        ]
      }
    },
    "ReferencesModule": {
      "ReferenceList": {
        "Reference": [
          {
            "ReferencePMID": "33246213",
            "ReferenceType": "result",
            "ReferenceCitation": "Souidi M, Amédro P, Meyer P, Desprat R, Lemaître JM, Rivier F, Lacampagne A, Meli AC. Generation of three Duchenne Muscular Dystrophy patient-specific induced pluripotent stem cell lines DMD_YoTaz_PhyMedEXp, DMD_RaPer_PhyMedEXp, DMD_OuMen_PhyMedEXp (INSRMi008-A, INSRMi009-A and INSRMi010-A). Stem Cell Res. 2020 Dec;49:102094. doi: 10.1016/j.scr.2020.102094. Epub 2020 Nov 19."
          }
        ]
      }
    }
  },
  "DerivedSection": {
    "MiscInfoModule": {
      "VersionHolder": "January 20, 2022"
    },
    "ConditionBrowseModule": {
      "ConditionMeshList": {
        "ConditionMesh": [
          {
            "ConditionMeshId": "D000009202",
            "ConditionMeshTerm": "Cardiomyopathies"
          }
        ]
      },
      "ConditionAncestorList": {
        "ConditionAncestor": [
          {
            "ConditionAncestorId": "D000006331",
            "ConditionAncestorTerm": "Heart Diseases"
          },
          {
            "ConditionAncestorId": "D000002318",
            "ConditionAncestorTerm": "Cardiovascular Diseases"
          }
        ]
      },
      "ConditionBrowseLeafList": {
        "ConditionBrowseLeaf": [
          {
            "ConditionBrowseLeafId": "M11306",
            "ConditionBrowseLeafName": "Cardiomyopathies",
            "ConditionBrowseLeafAsFound": "Cardiomyopathy",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M8571",
            "ConditionBrowseLeafName": "Heart Diseases",
            "ConditionBrowseLeafRelevance": "low"
          }
        ]
      },
      "ConditionBrowseBranchList": {
        "ConditionBrowseBranch": [
          {
            "ConditionBrowseBranchAbbrev": "BC14",
            "ConditionBrowseBranchName": "Heart and Blood Diseases"
          },
          {
            "ConditionBrowseBranchAbbrev": "All",
            "ConditionBrowseBranchName": "All Conditions"
          }
        ]
      }
    }
  }
}